- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Scottish 3-D firm shows big jump in U.S. sales
Edinburgh-based Voxar announced a four-fold increase in annual U.S. sales to $1 million, and says it is planning to go public within the next year.Voxar's Plug 'n View 3D, which allows rapid display of 3-D CT, MRI, and other images on standard PC
Edinburgh-based Voxar announced a four-fold increase in annual U.S. sales to $1 million, and says it is planning to go public within the next year.
Voxar's Plug 'n View 3D, which allows rapid display of 3-D CT, MRI, and other images on standard PC hardware, has shown marketing success in Europe and Japan as well, according to a company spokesperson.
The firm recently announced new funding of $7.2 million and said it plans to relocate to larger quarters and double its number of employees to 150 within the next year.
Investors have agreed to increase employee equity in Voxar from 10% to 15%, which will "provide a significant boost to our recruitment program," according to a statement by CEO Andrew Bissell.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
